Spironolactone reduces aldosterone-induced potassium/magnesium loss and myocardial fibrosis.
[3] It reduces hypertension,
[4] improves the endothelial function and reduces the overall morbidity and mortality in patients with chronic heart failure.
[5] Spironolactone improves nitric oxide bioactivity and vascular endothelial vasodilator dysfunction.
[3]